Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
results symbols : Meso save search
Mesoblast Reports Financial Results and Operational Update for Half-Year Ended December 31, 2023
Published: 2024-02-28 (Crawled : 23:00) - globenewswire.com
MESO | $6.21 3.5% 3.38% 200K
|
Health Technology
|
| O: -1.91%
H: 0.0%
C: -3.9%
update financial results
Mesoblast Financial Results and Corporate Update Webcast
Published: 2024-02-26 (Crawled : 12:00) - globenewswire.com
MESO | $6.21 3.5% 3.38% 200K
|
Health Technology
|
| O: -1.44%
H: 1.46%
C: -0.58%
update financial results
Mesoblast Reports Financial Results and Operational Update for Fiscal Year Ended June 30, 2023
Published: 2023-08-30 (Crawled : 23:00) - globenewswire.com
MESO | $6.21 3.5% 3.38% 200K
|
Health Technology
|
| O: 11.19%
H: 8.18%
C: 1.26%
year update financial results
Mesoblast Financial Results and Corporate Update Webcast
Published: 2023-08-29 (Crawled : 11:00) - globenewswire.com
MESO | $6.21 3.5% 3.38% 200K
|
Health Technology
|
| O: 1.96%
H: 0.0%
C: -5.13%
update financial results
Reunion Neuroscience Reports Fiscal Fourth Quarter and Full Year 2023 Financial Results and Provides a Corporate Update
Published: 2023-06-29 (Crawled : 12:00) - globenewswire.com
REUN | $1.12 -0.89% 0
|
Health Care and Social Assistan...
|
| O: -0.9%
H: 2.73%
C: 0.91%
JNJ | News | $148.53 -0.69% -0.14% 9.6M
|
Health Technology
|
| O: -0.2%
H: 1.03%
C: 0.9%
MESO | $6.21 3.5% 3.38% 200K
|
Health Technology
|
| O: 6.38%
H: 1.0%
C: -2.5%
year update financial results
Mesoblast Financial Results and Corporate Update Webcast
Published: 2023-05-24 (Crawled : 11:00) - globenewswire.com
MESO | $6.21 3.5% 3.38% 200K
|
Health Technology
|
| O: -2.72%
H: 0.56%
C: -2.24%
update financial results
Mesoblast Financial Results and Corporate Update Webcast
Published: 2022-11-21 (Crawled : 14:20) - globenewswire.com
MESO | $6.21 3.5% 3.38% 200K
|
Health Technology
|
| O: 5.5%
H: 2.15%
C: 0.0%
update financial results
DREAM-HF Phase 3 Trial Results for Mesoblast Cell Therapy in Heart Failure Published in Journal of the American College of Cardiology (JACC)
Published: 2023-02-27 (Crawled : 22:00) - globenewswire.com
MESO | $6.21 3.5% 3.38% 200K
|
Health Technology
|
| O: 3.44%
H: 2.42%
C: -0.3%
heart trial cardiology therapy
Mesoblast Financial Results and Corporate Update Webcast - February 27, 2023
Published: 2023-02-27 (Crawled : 06:00) - biospace.com/
MESO | $6.21 3.5% 3.38% 200K
|
Health Technology
|
| O: -0.31%
H: 0.0%
C: -0.31%
financial update results
Mesoblast Financial Results and Corporate Update Webcast
Published: 2023-02-27 (Crawled : 01:00) - globenewswire.com
MESO | $6.21 3.5% 3.38% 200K
|
Health Technology
|
| O: -0.31%
H: 0.0%
C: -0.31%
financial update results
Mesoblast Reports Financial Results and Operational Highlights for the Period Ended September 30, 2022
Published: 2022-11-22 (Crawled : 00:00) - globenewswire.com
MESO | $6.21 3.5% 3.38% 200K
|
Health Technology
|
| O: 3.08%
H: 0.15%
C: -0.3%
financial
Mesoblast Reports Financial Results and Operational Highlights for Fiscal Year Ended June 30, 2022
Published: 2022-08-30 (Crawled : 00:00) - globenewswire.com
MESO | $6.21 3.5% 3.38% 200K
|
Health Technology
|
| O: 8.06%
H: 2.0%
C: 0.34%
year
Mesoblast Corporate Update and Financial Results Webcast - Aug 30, 2022
Published: 2022-08-30 (Crawled : 06:00) - biospace.com/
MESO | $6.21 3.5% 3.38% 200K
|
Health Technology
|
| O: -0.36%
H: 1.43%
C: -2.15%
update results
Mesoblast Corporate Update and Financial Results Webcast
Published: 2022-08-30 (Crawled : 01:00) - globenewswire.com
MESO | $6.21 3.5% 3.38% 200K
|
Health Technology
|
| O: -0.36%
H: 1.43%
C: -2.15%
update results
Operational Highlights and Financial Results for the Period Ended March 31, 2022
Published: 2022-06-01 (Crawled : 01:00) - globenewswire.com
MESO | $6.21 3.5% 3.38% 200K
|
Health Technology
|
| O: -4.99%
H: 3.79%
C: 0.87%
Operational Highlights and Financial Results for the Period Ended December 31, 2021
Published: 2022-02-24 (Crawled : 23:00) - globenewswire.com
MESO | $6.21 3.5% 3.38% 200K
|
Health Technology
|
| O: -0.76%
H: 3.33%
C: 1.79%
financial results results
Mesoblast Corporate Update and Financial Results Webcast - Feb 24, 2022
Published: 2022-02-24 (Crawled : 12:00) - biospace.com/
MESO | $6.21 3.5% 3.38% 200K
|
Health Technology
|
| O: -1.06%
H: 6.68%
C: 5.08%
financial results results
Mesoblast Corporate Update and Financial Results Webcast
Published: 2022-02-24 (Crawled : 11:00) - globenewswire.com
MESO | $6.21 3.5% 3.38% 200K
|
Health Technology
|
| O: -1.06%
H: 6.68%
C: 5.08%
financial results results
Single Dose of Mesoblast’s Allogeneic Cell Therapy Provides Durable Pain Reduction for at Least Three Years in Patients With Degenerative Disc Disease36-Month Results of Phase 3 Trial in Chronic Low Back Pain Presented at 2022 Biotech Showcase
Published: 2022-01-12 (Crawled : 06:00) - biospace.com/
MESO | $6.21 3.5% 3.38% 200K
|
Health Technology
|
| O: 6.4%
H: 0.0%
C: -3.21%
phase 3
Operational Highlights and Financial Results for the Period Ended September 30, 2021
Published: 2021-11-23 (Crawled : 00:00) - globenewswire.com
MESO | $6.21 3.5% 3.38% 200K
|
Health Technology
|
| O: -0.63%
H: 0.0%
C: 0.0%
financial results results
Gainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M
|
Consumer Services
BOF | $1.99 70.09% 41.21% 110M
|
ILAG | $0.51 6.03% 40.62% 1.7M
|
LICN | $0.941 68.04% 40.49% 15M
|
AMST | $3.31 65.5% 39.58% 70M
|
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.45 12.5% 30.92% 320K
|
Health Services
MULN | News | $3.78 38.46% 27.78% 13M
|
Information
RILY | $29.86 37.48% 27.26% 12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.